CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
|
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS | ||||
| Revenue from collaboration and licensing | $ 6,685 | $ 4,051 | $ 10,381 | $ 6,286 |
| Operating expenses: | ||||
| Research and development | (11,564) | (13,929) | (23,090) | (24,108) |
| General and administrative | (4,347) | (3,751) | (8,976) | (6,462) |
| Total operating expenses | (15,911) | (17,680) | (32,066) | (30,570) |
| Loss from operations | (9,226) | (13,629) | (21,685) | (24,284) |
| Other income (expense): | ||||
| Grant income | 1,595 | 1,544 | 3,067 | 2,736 |
| Interest income | 59 | 511 | 371 | 575 |
| Interest expense | (166) | (210) | (393) | (423) |
| Other income and expenses, net | 646 | (195) | 622 | 88 |
| Total other income, net | 2,134 | 1,650 | 3,667 | 2,976 |
| Net loss before tax | (7,092) | (11,979) | (18,018) | (21,308) |
| Income tax expense | 0 | (100) | 0 | (100) |
| Net loss | (7,092) | (12,079) | (18,018) | (21,408) |
| Other comprehensive loss: | ||||
| Foreign currency translation gain (loss), net of tax | (133) | 300 | (226) | (435) |
| Comprehensive loss | $ (7,225) | $ (11,779) | $ (18,244) | $ (21,843) |
| Net loss per share - basic and diluted | $ (0.28) | $ (0.63) | $ (0.70) | $ (2.10) |
| Weighted average common shares outstanding — basic and diluted | 25,647,819 | 19,240,977 | 25,638,913 | 10,174,157 |